DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6Dr. Reddy's Laboratories
02 1Supriya Lifescience
03 36Accord healthcare
04 4Accure Labs
05 3Actavis Inc
06 2Alembic Pharmaceuticals Limited
07 1Almaject
08 2Amneal Pharmaceuticals
09 3Aurobindo Pharma Limited
10 2Ayana Pharma
11 17Baxter Healthcare Corporation
12 7Bayer AG
13 1Bluepharma
14 3Bristol Myers Squibb
15 1CKD Otto Pharma
16 1Central Procurement & Supplies Unit
17 4Cheplapharm Arzneimittel Gmbh
18 2Cipla Medpro South Africa
19 1Copharma Aps
20 1Deva Holding AS
21 1Eugia Pharma
22 2Flagship Biotech International Pvt. Ltd
23 1Fresenius Kabi USA
24 2Fresenius SE & Co. KGaA
25 1GLAND PHARMA LIMITED
26 6GetWell Pharmaceutical
27 1Health Biotech
28 1Healthcare Pharmaceuticals
29 5Hikma Pharmaceuticals
30 1Intelliscend
31 1JV Healthcare Limited
32 1Janssen-Cilag
33 2Jodas Expoim Pvt. Ltd
34 2Karo Pharma
35 3Key Oncologics
36 2Lupin Ltd
37 5Naprod Life Sciences
38 2Nishchay Pharmaceuticals Pvt. Ltd.
39 4Oethmaan Biosims
40 1PHARMOBEDIENT
41 1Panacea Biotec Limited
42 2Pfizer Consumer Healthcare
43 30Pfizer Inc
44 13Pharmachemie
45 1Pharmaplan
46 1Powercliff Limited
47 1Prohealth Limited
48 3SEACROSS PHARMACEUTICALS
49 1STADA Arzneimittel
50 1Sagent Pharmaceuticals
51 3Sakar Healthcare
52 12Sandoz B2B
53 1Sanoswiss Uab
54 10Sun Pharmaceutical Industries Limited
55 1Taro Pharmaceutical Industries
56 1Tedec Meiji Farma
57 14Teva Pharmaceutical Industries
58 4TherDose Pharma
59 6Viatris
60 2Vinkem Labs Ltd
61 1Zhejiang Hisun Pharmaceutical
62 2Zydus Lifesciences
01 4Concentrate For Dispersion For Infusion
02 4Concentrate For Infusion Solution
03 38Concentrate For Solution For Infusion
04 1Doxorubicin 100Mg 50Ml 1 Units Parenteral Use
05 6Doxorubicin 10Mg 5Ml 1 Units Parenteral Use
06 3Doxorubicin 200Mg 100Ml 1 Units Parenteral Use
07 1Doxorubicin 20Mg 10Ml 1 Units Parenteral Use
08 1Doxorubicin 50Mg 1 Unit Parenteral Use
09 1Doxorubicin 50Mg 2 Units Parenteral Use
10 4Doxorubicin 50Mg 25Ml 1 Units Parenteral Use
11 11INF
12 23INJ
13 16INJECTABLE, LIPOSOMAL;INJECTION
14 38INJECTABLE;INJECTION
15 6INJECTION
16 1Infusion Dispersion
17 4Injectable Solution
18 1Injectable; Injection
19 23Injection
20 1Liposomal Injection
21 1Liposome Injection
22 1Liquid Injection
23 2Lyo.Inj
24 2Lyophilised Injection
25 1POI
26 2POWDER FOR SOLUTION
27 1Powder Dispersion And Solvent For Concentrate For Dispersion For Infusion
28 3Powder For Concentrate For Solution For Infusion
29 1Powder For Dispersion Concentrate For Infusion
30 1Powder For Injectable Solution
31 5Powder For Solution For Injection
32 2SOL
33 6SOLUTION
34 2SUSPENSION
35 1Solution For Infusion
36 18Solution For Injection
37 1Vial
38 16Blank
01 21Allowed
02 7Approved
03 3Authorised
04 8Authorized
05 1Cancelled
06 22DISCN
07 7Deregistered
08 45Generic
09 2Lead Market Dossiers- Approved in US and Under review in EU
10 1Lead Market Dossiers- Filed
11 10Marketed
12 5Not Marketed
13 6Originator
14 14Prescription
15 32RX
16 4Withdrawn
17 65Blank
01 2ADRIAMYCIN PFS
02 6Adriamycin
03 2Adriblastin RD
04 3Adriblastin Solution
05 5Adriblastina
06 1Adriblastina CSV 10mg/5ml
07 1Adriblastina CSV 50mg/25ml
08 1Adriblastina RD 10mg
09 1Adriblastina RD 50mg
10 1CAELYX
11 10Caelyx
12 4Caelyx Pegylated Liposomal
13 4Caelyx pegylated liposomal
14 2Celdoxome Pegylated Liposomal
15 1Cipla Doxorubicin 10
16 1Cipla Doxorubicin 50
17 2DOXIL (LIPOSOMAL)
18 1DOXOPEG
19 4DOXORUBA
20 1DOXORUBICIN
21 1DOXORUBICIN -SOL PCH 10MG
22 1DOXORUBICIN 10mg/5ml FRESENIUS
23 1DOXORUBICIN 50mg/25ml FRESENIUS
24 33DOXORUBICIN HYDROCHLORIDE
25 14DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
26 2DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
27 1DOXORUBICIN HYDROCHLORIDE INJECTION
28 1DOXORUBICIN INJECTION, BP
29 1DOXORUBICIN-SOL PCH 50MG
30 2DOXOTHER
31 1Doxolip
32 1Doxonish 10
33 1Doxonish 50
34 13Doxorubicin
35 1Doxorubicin "Ebewe" 10mg (5ml vial)
36 1Doxorubicin "Ebewe" 50mg (25ml vial)
37 1Doxorubicin - Pch 10
38 2Doxorubicin ACC
39 11Doxorubicin Accord
40 1Doxorubicin Accord 10mg/5ml
41 1Doxorubicin Accord 2 Mg/Ml
42 1Doxorubicin Accord 50mg/25ml
43 2Doxorubicin Accord liposomal
44 3Doxorubicin Actavis
45 1Doxorubicin Aurovitas
46 1Doxorubicin Copharma
47 4Doxorubicin Ebewe
48 1Doxorubicin Ebewe""
49 2Doxorubicin Mylan
50 1Doxorubicin Mylan Concentrate For Soln For Inf
51 1Doxorubicin Mylan Pdr/Conc/Soln For Infus
52 1Doxorubicin Pch
53 1Doxorubicin Pch 10 10Mg Vial
54 1Doxorubicin Pch 50
55 1Doxorubicin Rtu
56 1Doxorubicin Rtu 10-5 5Ml
57 1Doxorubicin Rtu 200-100 100Ml
58 1Doxorubicin Rtu 50-25 25Ml
59 4Doxorubicin Sandoz eco
60 1Doxorubicin Sanoswiss
61 1Doxorubicin Stada
62 3Doxorubicin Teva
63 1Doxorubicin hcl faulfing powder vial
64 1Doxorubicin-Hexal 10Mg/5Ml
65 1Doxorubicin-Hexal 50Mg/25Ml
66 4Doxorubicin-Teva
67 5Doxorubicin? Accord 2 mg/ml
68 1Doxorubicina Tedec
69 1Doxred 10 Lyophilized Powder
70 1Doxred 10mg/5ml
71 1Doxred 50 Lyophilized Powder
72 1Doxred 50mg/25ml
73 2Farmiblastina
74 2I-DOX
75 1Kemodoxin
76 6Liposomal Doxorubicin SUN
77 1Myocet
78 3Myocet Liposomal
79 1Myocet liposomal
80 3RUBEX
81 1Ribodoxo
82 1Rubexet 10mg/5ml
83 1Rubexet 200mg/100ml
84 1Rubexet 50mg/25ml
85 1Sopilcin 20 mg/10 ml
86 1TARO-DOXORUBICIN LIPOSOMAL
87 1Zolsketil
88 2Zolsketil Pegylated Liposomal
89 2Zolsketil pegylated liposomal
90 29Blank
01 16Australia
02 7Canada
03 7Estonia
04 35India
05 1Indonesia
06 17Italy
07 7Malta
08 8Moldova
09 15Norway
10 1Portugal
11 37South Africa
12 9Spain
13 14Sweden
14 21Switzerland
15 1Turkey
16 54USA
17 3United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG/10ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG/25ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Sopilcin 20 mg/10 ml
Dosage Form : INF
Dosage Strength : 2mg/ml
Packaging : 10X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 1995-11-17
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2000-06-13
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1985-05-20
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/VIAL
Packaging :
Approval Date : 1987-07-22
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG/ML
Packaging :
Approval Date : 1987-12-23
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 200MG/100ML
Packaging :
Approval Date : 1988-05-03
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/75ML
Packaging :
Approval Date : 2011-03-28
Application Number : 50629
Regulatory Info : DISCN
Registration Country : USA
